In fact, in line with recent studies from our group addressing V-ATPase in cancer [15, 44], our results presented here suggest that Archazolid decreased survivin at the protein level by inducing S-phase cell cycle arrest in leukemic cells which probably was due to its interference with the iron metabolism. The gene discussed is BIRC5; the disease is cancer.